| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 139.25B | 138.26B | 132.05B | 125.94B | 117.66B |
| Gross Profit | 16.93B | 15.80B | 15.04B | 13.60B | 13.21B |
| EBITDA | 8.25B | 7.49B | 6.50B | 4.97B | 5.15B |
| Net Income | 4.84B | 3.72B | 3.40B | 3.04B | 3.22B |
Balance Sheet | |||||
| Total Assets | 163.10B | 157.17B | 150.87B | 128.06B | 114.63B |
| Cash, Cash Equivalents and Short-Term Investments | 20.87B | 25.84B | 24.07B | 20.32B | 12.97B |
| Total Debt | 35.95B | 36.41B | 34.85B | 18.64B | 16.19B |
| Total Liabilities | 108.68B | 106.71B | 102.07B | 82.33B | 70.76B |
| Stockholders Equity | 54.33B | 50.36B | 48.79B | 45.72B | 43.86B |
Cash Flow | |||||
| Free Cash Flow | 1.64B | 0.00 | -11.88B | 5.64B | -7.81B |
| Operating Cash Flow | 3.54B | 0.00 | -9.99B | 6.33B | -6.19B |
| Investing Cash Flow | -4.65B | -1.35B | -1.44B | -508.00M | -1.77B |
| Financing Cash Flow | -4.02B | 207.00M | 14.91B | 1.45B | -4.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥44.54B | 10.32 | ― | 1.96% | 24.91% | 51.00% | |
73 Outperform | ¥41.42B | 8.82 | ― | 3.97% | -3.24% | 60.95% | |
70 Outperform | ¥46.62B | 11.14 | ― | 3.78% | 24.67% | 72.89% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥62.23B | 10.49 | ― | 0.79% | 0.81% | -53.76% | |
61 Neutral | ¥37.61B | 7.80 | ― | 3.88% | 0.72% | 30.10% | |
60 Neutral | ¥57.30B | 14.53 | ― | 1.57% | 4.01% | 21.41% |